SNP information rs28371725

Research and publications:

  20174590   Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms.

  20548328   High-efficiency genotype analysis from formalin-fixed, paraffin-embedded tumor tissues.

  20650817   Functional intronic polymorphisms: Buried treasure awaiting discovery within our genes.

  20847277   Genotyping of DNA samples isolated from formalin-fixed paraffin-embedded tissues using preamplification.

  21071160   Analysis of 50 SNPs in CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP1A2 by MALDI-TOF mass spectrometry in Chinese Han population.

  21192344   CYP2C19 variation and citalopram response.

  21289622   Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy.

  21480951   Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients.

  21790905   CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.

  22448283   Genotyping performance between saliva and blood-derived genomic DNAs on the DMET array: a comparison.

  22479249   Whole genome amplification of DNA for genotyping pharmacogenetics candidate genes.

  22482072   Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.

  24200957   Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit.

  24798984   Developing and Evaluating the HRM Technique for Identifying Cytochrome P450 2D6 Polymorphisms.

  24868171   Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders.

  25266489   Genetic polymorphisms of VIP variants in the Tajik ethnic group of northwest China.

  25419701   Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations.

  26091847   Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China.

  26369774   Impact of New Genomic Technologies on Understanding Adverse Drug Reactions.

  26793106   CYP2D7 Sequence Variation Interferes with TaqMan CYP2D6 (*) 15 and (*) 35 Genotyping.

  26858644   Cross-Comparison of Exome Analysis, Next-Generation Sequencing of Amplicons, and the iPLEX(®) ADME PGx Panel for Pharmacogenomic Profiling.

  27108086   Multiplex SNaPshot-a new simple and efficient CYP2D6 and ADRB1 genotyping method.

  27171561   Liver Function Test Abnormalities in Depressed Patients Treated with Antidepressants: A Real-World Systematic Observational Study in Psychiatric Settings.

  27233804   Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China.

  27467145   Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses.

  27785397   CYP2D6 allele distribution in Macedonians, Albanians and Romanies in the Republic of Macedonia.

  27942231   CYP2D6 polymorphisms and their influence on risperidone treatment.

  28178648   Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.

  29193749   Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years.

  29369497   Pharmacogenetics of Risperidone-Induced Insulin Resistance in Children and Adolescents with Autism Spectrum Disorder.

  29750612   Higher than expected clozapine serum level and clozapine/norclozapine ratio due to CYP450 gene polymorphisms.

  29789925   Associations of polymorphisms of CYP2D6 and CYP2C9 with early onset severe pre-eclampsia and response to labetalol therapy.

  30068618   Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark.

  30093869   Biological Predictors of Clozapine Response: A Systematic Review.

  30452466   Characterization of ADME genes variation in Roma and 20 populations worldwide.

  31019283   Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests.

  31858263   Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population.

  32639515   Bayesian Pathway Analysis for Complex Interactions.

  33262486   Abstracts from the 53rd European Society of Human Genetics (ESHG) Conference: e-Posters.

  33519226   Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon.

  34366834   CYP2D6 Allele Frequency in Five Malaria Vivax Endemic Areas From Brazilian Amazon Region.

  34385834   Individualized drug selection by assessing drug properties, pharmacogenomics, and clinical parameters: effectiveness of a bioinformatics tool compared to a clinically established counseling process.

  34621706   Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform.

  34958284   Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes.